Home › Multiple Myeloma › New Jersey › Edison
Multiple Myeloma clinical trials in Edison, NJ
21 studies for Multiple Myeloma are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RecruitingPhase 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RecruitingPhase 3
- Astera Cancer Care, East Brunswick · 6 mi away
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
RecruitingPhase 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
RecruitingPhase 3
- MSK Basking Ridge, Basking Ridge · 15 mi away
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
RecruitingPhase 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
RecruitingObservational study
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
RecruitingPhase 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi away
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Recruiting
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi away
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
RecruitingPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 3
- Astera Cancer Care, East Brunswick · 6 mi away
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
RecruitingPhase 3
- MSK Basking Ridge, Basking Ridge · 15 mi away
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RecruitingPhase 3
- Research Site, East Brunswick · 6 mi away
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
RecruitingPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
RecruitingPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
RecruitingEarly phase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 3 mi away
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 3 mi away
A Dietary Study for People With Multiple Myeloma
Recruiting
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
RecruitingPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY59 studies
- Boston, MA45 studies
- Atlanta, GA42 studies
- Houston, TX39 studies
- Durham, NC36 studies
- Nashville, TN31 studies
- Denver, CO26 studies
- St. Louis, MO26 studies
- Rochester, MN25 studies
- Columbus, OH25 studies
- Chicago, IL24 studies
- Milwaukee, WI23 studies
Other studies in Edison
- Breast Cancer70 studies
- Non-Small Cell Lung Cancer50 studies
- Cancer (all types)33 studies
- Prostate Cancer29 studies
- Colorectal Cancer25 studies
- Lung Cancer25 studies
- Bladder Cancer23 studies
- Metastatic Cancer20 studies
- Endometrial Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Ovarian Cancer19 studies
- Pancreatic Cancer18 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.